IL308684A - Methods of treating breast cancer - Google Patents

Methods of treating breast cancer

Info

Publication number
IL308684A
IL308684A IL308684A IL30868423A IL308684A IL 308684 A IL308684 A IL 308684A IL 308684 A IL308684 A IL 308684A IL 30868423 A IL30868423 A IL 30868423A IL 308684 A IL308684 A IL 308684A
Authority
IL
Israel
Prior art keywords
methods
breast cancer
treating breast
treating
cancer
Prior art date
Application number
IL308684A
Other languages
English (en)
Hebrew (he)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IL308684A publication Critical patent/IL308684A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • A61K31/502Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
IL308684A 2021-06-02 2022-05-31 Methods of treating breast cancer IL308684A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163195795P 2021-06-02 2021-06-02
PCT/EP2022/064697 WO2022253800A1 (en) 2021-06-02 2022-05-31 Methods of treating breast cancer

Publications (1)

Publication Number Publication Date
IL308684A true IL308684A (en) 2024-01-01

Family

ID=82117716

Family Applications (1)

Application Number Title Priority Date Filing Date
IL308684A IL308684A (en) 2021-06-02 2022-05-31 Methods of treating breast cancer

Country Status (12)

Country Link
US (1) US20240269135A1 (https=)
EP (1) EP4346828A1 (https=)
JP (1) JP2024520142A (https=)
KR (1) KR20240016344A (https=)
CN (1) CN118139624A (https=)
AU (1) AU2022286616A1 (https=)
BR (1) BR112023025003A2 (https=)
CA (1) CA3220751A1 (https=)
CL (1) CL2023003533A1 (https=)
IL (1) IL308684A (https=)
MX (1) MX2023014420A (https=)
WO (1) WO2022253800A1 (https=)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1633724T3 (pl) 2003-03-12 2011-10-31 Kudos Pharm Ltd Pochodne ftalazynonu

Also Published As

Publication number Publication date
JP2024520142A (ja) 2024-05-21
CA3220751A1 (en) 2022-12-08
MX2023014420A (es) 2024-04-23
CN118139624A (zh) 2024-06-04
WO2022253800A1 (en) 2022-12-08
US20240269135A1 (en) 2024-08-15
KR20240016344A (ko) 2024-02-06
BR112023025003A2 (pt) 2024-02-20
AU2022286616A1 (en) 2024-01-18
EP4346828A1 (en) 2024-04-10
CL2023003533A1 (es) 2024-06-28

Similar Documents

Publication Publication Date Title
SI4181920T1 (sl) Inhibitor kat6 in kombinacije za zdravljenje raka dojke
IL304275A (en) Cancer treatment methods
IL289297B1 (en) Adjuvant treatment for her2-positive breast cancer
IL312680A (en) Cancer treatment methods
IL284850A (en) Methods of treating breast cancer with toctinib
IL277981A (en) Cancer treatment methods
SG11202010793UA (en) Methods of treating cancer
IL281600B2 (en) Cancer treatment methods
IL289811A (en) A method for treating cancer
SG11202107017TA (en) Methods of treating cancer
GB202107994D0 (en) Treatment of cancer
IL305780A (en) Cancer treatment methods
IL312155A (en) A method for treating cancer
IL272390A (en) Cancer treatment methods
IL308684A (en) Methods of treating breast cancer
IL314687A (en) Cancer treatment
IL312332A (en) Cancer treatment methods
HK40110390A (zh) 治疗乳腺癌的方法
IL269295A (en) Methods of treating breast cancer
IL315569A (en) Cancer treatment methods
GB201918815D0 (en) Treatment of cancer
IL307632A (en) Cancer treatment methods
GB202018062D0 (en) Treatment of cancer
GB202008037D0 (en) Treatment of cancer
GB202006474D0 (en) Method of treatment of cancer or tumour